-
1
-
-
84936067779
-
-
WHO 2008
-
WHO 2008
-
-
-
-
2
-
-
34249033328
-
Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis
-
17404367
-
Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis. J Clin Oncol. 2007;25(13):1683-90.
-
(2007)
J Clin Oncol
, vol.25
, Issue.13
, pp. 1683-1690
-
-
Jatoi, I.1
Chen, B.E.2
Anderson, W.F.3
Rosenberg, P.S.4
-
4
-
-
12844270607
-
Breast Cancer in African American women
-
15632248
-
Newman LA. Breast Cancer in African American women. Oncologist. 2005;10:1-14.
-
(2005)
Oncologist
, vol.10
, pp. 1-14
-
-
Newman, L.A.1
-
5
-
-
33744960226
-
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
-
1:CAS:528:DC%2BD28XlsV2rtLw%3D 16757721
-
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-502.
-
(2006)
JAMA
, vol.295
, pp. 2492-2502
-
-
Carey, L.A.1
Perou, C.M.2
Livasy, C.A.3
Dressler, L.G.4
Cowan, D.5
Conway, K.6
Karaca, G.7
Troester, M.8
Kit Tse, C.9
Edmiston, S.10
Deming, S.L.11
Geradts, J.12
Cheang, M.C.U.13
Nielsen, T.O.14
Moorman, P.G.15
Shelton Earp, H.16
Millikan, R.C.17
-
6
-
-
69249194944
-
Treatment of Breast Cancer in Accra: 5 year Survival
-
Baako BN, Badoe EA. Treatment of Breast Cancer in Accra: 5 year Survival. Ghana Med J. 2001;35:90-5.
-
(2001)
Ghana Med J
, vol.35
, pp. 90-95
-
-
Baako, B.N.1
Badoe, E.A.2
-
7
-
-
77953248475
-
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10
-
159 Cases from 12 Studies
-
Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, et al. (2010) Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies. PLoS Med 7(5): e1000279. doi: 10.1371/journal.pmed.1000279
-
(2010)
PLoS Med
, vol.7
, Issue.5
, pp. e1000279
-
-
Blows, F.M.1
Driver, K.E.2
Schmidt, M.K.3
Broeks, A.4
Van Leeuwen, F.E.5
-
8
-
-
78751607122
-
Characteristics of triple-negative breast cancer
-
1:CAS:528:DC%2BC3MXkt1SntA%3D%3D 3018596 21069385
-
de Ruijter TC, Veeck J, de Hoon JPJ, van Engeland M, Tjan-Heijnen VC. Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol. 2011;137:183-92.
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 183-192
-
-
De Ruijter, T.C.1
Veeck, J.2
De Hoon, J.P.J.3
Van Engeland, M.4
Tjan-Heijnen, V.C.5
-
9
-
-
23844549918
-
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
-
1:CAS:528:DC%2BD2MXos1Cjs7k%3D 16115903
-
Rouzier R, Perou CM, Fraser Symmans W, Ibrahim N, Cristofanilli M, Anderson K, et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy. Clin Cancer Res. 2005;11:5678-85.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5678-5685
-
-
Rouzier, R.1
Perou, C.M.2
Fraser Symmans, W.3
Ibrahim, N.4
Cristofanilli, M.5
Anderson, K.6
Hess, K.R.7
Stec, J.8
Ayers, M.9
Wagner, P.10
Morandi, P.11
Fan, C.12
Rabiul, I.13
Ross, J.S.14
Hortobagyi, G.N.15
Pusztai, L.16
-
10
-
-
0035754641
-
Who should not receive adjuvant chemotherapy? International databases
-
11773301
-
Bergh J, Holmquist M. Who should not receive adjuvant chemotherapy? International databases. J Natl Cancer Inst Monogr. 2001;30:103-8.
-
(2001)
J Natl Cancer Inst Monogr
, vol.30
, pp. 103-108
-
-
Bergh, J.1
Holmquist, M.2
-
11
-
-
78249243445
-
African Ancestry and Higher Prevalence of Triple-Negative Breast Cancer
-
3138711 20629078
-
Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, et al. African Ancestry and Higher Prevalence of Triple-Negative Breast Cancer. Cancer. 2010;116:4926-32.
-
(2010)
Cancer
, vol.116
, pp. 4926-4932
-
-
Stark, A.1
Kleer, C.G.2
Martin, I.3
Awuah, B.4
Nsiah-Asare, A.5
Takyi, V.6
Braman, M.7
Quayson, S.E.8
Zarbo, R.9
Wicha, M.10
Newman, L.11
-
12
-
-
44849129524
-
Immunohistochemical and molecular subtypes of breast cancer in Nigeria
-
1:CAS:528:DC%2BD1cXmslyjsr4%3D 17674190
-
Adebamowo AC, Famooto A, Ogundiran OT, Aniagwu T, Nkwodimmah C, Akang EE. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2008;110:183-8.
-
(2008)
Breast Cancer Res Treat
, vol.110
, pp. 183-188
-
-
Adebamowo, A.C.1
Famooto, A.2
Ogundiran, O.T.3
Aniagwu, T.4
Nkwodimmah, C.5
Akang, E.E.6
-
13
-
-
70449185514
-
Histological grading and prognosis in breast cancer; A study of 1409 cases of which 359 have been followed for 15 years
-
1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D 2073885 13499785
-
Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11(3):359-77.
-
(1957)
Br J Cancer
, vol.11
, Issue.3
, pp. 359-377
-
-
Bloom, H.J.1
Richardson, W.W.2
-
14
-
-
84866455237
-
Breast cancer in Kumasi, Ghana
-
1:STN:280:DC%2BC38nkt1WmtA%3D%3D 3353503 22605883
-
Ohene-Yeboah M, Adjei E. Breast cancer in Kumasi, Ghana. Ghana Med J. 2012;46(1):8-13.
-
(2012)
Ghana Med J
, vol.46
, Issue.1
, pp. 8-13
-
-
Ohene-Yeboah, M.1
Adjei, E.2
-
15
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou CM, Sùrlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406.
-
Nature
, vol.2000
, pp. 406
-
-
Perou Cm, S.1
-
16
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
Sørliea T, Perou CM, Tibshiranie R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(199):10869-74.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, Issue.199
, pp. 10869-10874
-
-
Sørliea, T.1
Perou, C.M.2
Tibshiranie, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
Van De Rijn, M.9
Jeffrey, S.S.10
Thorsen, T.11
Quist, H.12
Matese, J.C.13
Brown, P.O.14
Botstein, D.15
Lønning, P.E.16
Børresen-Daleb, A.L.17
-
17
-
-
4143150688
-
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
-
1:CAS:528:DC%2BD2cXmvFSlt7k%3D 15328174
-
Nielsen TO, Hsu FD, Jensen K, Cheng M, Karaca G, Hu Z, et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma. Clin Cancer Res. 2004;10:5367-74.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5367-5374
-
-
Nielsen, T.O.1
Hsu, F.D.2
Jensen, K.3
Cheng, M.4
Karaca, G.5
Hu, Z.6
-
18
-
-
71049148231
-
Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
-
1:CAS:528:DC%2BD1MXhtlCns77P 2754904 19704069
-
Huo D, Ikpatt F, Khramtsov A, Dangou J-M, Nanda R, Dignam J, et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer. J Clin Oncol. 2009;27:4515-21.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4515-4521
-
-
Huo, D.1
Ikpatt, F.2
Khramtsov, A.3
Dangou, J.-M.4
Nanda, R.5
Dignam, J.6
Zhang, B.7
Grushko, T.8
Zhang, C.9
Oluwasola, O.10
Malaka, D.11
Malami, S.12
Odetunde, A.13
Adeoye, A.O.14
Iyare, F.15
Falusi, A.16
Perou, C.M.17
Olapade, I.O.18
-
19
-
-
84865122721
-
Invasive breast carcinomas in Ghana: High frequency of high grade, basal-like histology and high EZH2 expression
-
1:CAS:528:DC%2BC38XhtFOkurvM 3906643 22527102
-
Pang J, Toy KA, Griffith KA, Awuah B, Quayson S, Newman LA, et al. Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression. Breast Cancer Res Treat. 2012;135(1):59-66.
-
(2012)
Breast Cancer Res Treat
, vol.135
, Issue.1
, pp. 59-66
-
-
Pang, J.1
Toy, K.A.2
Griffith, K.A.3
Awuah, B.4
Quayson, S.5
Newman, L.A.6
Kleer, C.G.7
-
20
-
-
34047264801
-
Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study
-
1:CAS:528:DC%2BD2sXjt1Srt7s%3D 17372238
-
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study. Cancer Epidemiol Biomarkers Prev. 2007;16:439-43.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 439-443
-
-
Yang, X.R.1
Sherman, M.E.2
Rimm, D.L.3
Lissowska, J.4
Brinton, L.A.5
Peplonska, B.6
Hewitt, S.M.7
Anderson, W.F.8
Szeszenia-Da-Browska, N.9
Bardin-Mikolajczak, A.10
Zatonski, W.11
Cartun, R.12
Mandich, D.13
Rymkiewicz, G.14
Ligaj, M.15
Lukaszek, S.16
Kordek, R.17
Garcĺa-Closas, M.18
-
21
-
-
0036569877
-
The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
-
1:CAS:528:DC%2BD38XktVKrs7o%3D 11981002
-
Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol. 2002;20(9):2310-8.
-
(2002)
J Clin Oncol
, vol.20
, Issue.9
, pp. 2310-2318
-
-
Lakhani, S.R.1
Van De Vijver, M.J.2
Jacquemier, J.3
Anderson, T.J.4
Osin, P.P.5
McGuffog, L.6
Easton, D.F.7
-
22
-
-
0141429017
-
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
-
1:CAS:528:DC%2BD3sXnvVCjtrk%3D 14519755
-
Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95(19):1482-5.
-
(2003)
J Natl Cancer Inst
, vol.95
, Issue.19
, pp. 1482-1485
-
-
Foulkes, W.D.1
Stefansson, I.M.2
Chappuis, P.O.3
Begin, L.R.4
Goffin, J.R.5
Wong, N.6
Trudel, M.7
Akslen, L.A.8
-
23
-
-
84863984125
-
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: Implications for genetic screening selection criteria: A Hellenic Cooperative Oncology Group Study
-
1:CAS:528:DC%2BC38XhtVGhtrbM 22434525
-
Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, et al. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat. 2012;134(1):353-62.
-
(2012)
Breast Cancer Res Treat
, vol.134
, Issue.1
, pp. 353-362
-
-
Fostira, F.1
Tsitlaidou, M.2
Papadimitriou, C.3
Pertesi, M.4
Timotheadou, E.5
Stavropoulou, A.V.6
Glentis, S.7
Bournakis, E.8
Bobos, M.9
Pectasides, D.10
Papakostas, P.11
Pentheroudakis, G.12
Gogas, H.13
Skarlos, P.14
Samantas, E.15
Bafaloukos, D.16
Kosmidis, P.A.17
Koutras, A.18
Yannoukakos, D.19
Konstantopoulou, I.20
Fountzilas, G.21
more..
-
24
-
-
64749086562
-
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
-
1:CAS:528:DC%2BD1MXjvVSitLg%3D 2666759 19298662
-
Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J, et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009;9:86.
-
(2009)
BMC Cancer
, vol.9
, pp. 86
-
-
Young, S.R.1
Pilarski, R.T.2
Donenberg, T.3
Shapiro, C.4
Hammond, L.S.5
Miller, J.6
Brooks, K.A.7
Cohen, S.8
Tenenholz, B.9
Desai, D.10
Zandvakili, I.11
Royer, R.12
Li, S.13
Narod, S.A.14
-
25
-
-
84925389000
-
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
-
1:CAS:528:DC%2BC2MXjs1Gktrw%3D 25716084
-
Villarreal-Garza C, Weitzel JN, Llacuachaqui M, Sifuentes E, Magallanes-Hoyos MC, Gallardo L, et al. The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Res Treat. 2015;150(2):389-94.
-
(2015)
Breast Cancer Res Treat
, vol.150
, Issue.2
, pp. 389-394
-
-
Villarreal-Garza, C.1
Weitzel, J.N.2
Llacuachaqui, M.3
Sifuentes, E.4
Magallanes-Hoyos, M.C.5
Gallardo, L.6
Alvarez-Gómez, R.M.7
Herzog, J.8
Castillo, D.9
Royer, R.10
Akbari, M.11
Lara-Medina, F.12
Herrera, L.A.13
Mohar, A.14
Narod, S.A.15
-
26
-
-
33748065304
-
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
-
1:CAS:528:DC%2BD28XotFWqtLg%3D 16912188
-
McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 2006;66(16):8109-15.
-
(2006)
Cancer Res
, vol.66
, Issue.16
, pp. 8109-8115
-
-
McCabe, N.1
Turner, N.C.2
Lord, C.J.3
Kluzek, K.4
Bialkowska, A.5
Swift, S.6
Giavara, S.7
O'Connor, M.J.8
Tutt, A.N.9
Zdzienicka, M.Z.10
Smith, G.C.11
Ashworth, A.12
-
27
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-717.
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
28
-
-
60349102490
-
Treatment of established breast cancer in post-menopausal women: Role of aromatase inhibitors
-
1:STN:280:DC%2BD1M7ms1OmtQ%3D%3D 19241985
-
Samphao S, Eremin JM, El-Sheemy M, Eremin O. Treatment of established breast cancer in post-menopausal women: role of aromatase inhibitors. Surgeon. 2009;7(1):42-55.
-
(2009)
Surgeon
, vol.7
, Issue.1
, pp. 42-55
-
-
Samphao, S.1
Eremin, J.M.2
El-Sheemy, M.3
Eremin, O.4
-
29
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
-
1:CAS:528:DC%2BD2MXhtFansr3F 16236738
-
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353(16):1673-84.
-
(2005)
N Engl J Med
, vol.353
, Issue.16
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
Suman, V.J.4
Geyer, Jr.C.E.5
Davidson, N.E.6
Tan-Chiu, E.7
Martino, S.8
Paik, S.9
Kaufman, P.A.10
Swain, S.M.11
Pisansky, T.M.12
Fehrenbacher, L.13
Kutteh, L.A.14
Vogel, V.G.15
Visscher, D.W.16
Yothers, G.17
Jenkins, R.B.18
Brown, A.M.19
Dakhil, S.R.20
Mamounas, E.P.21
Lingle, W.L.22
Klein, P.M.23
Ingle, J.N.24
Wolmark, N.25
more..
-
30
-
-
77953345188
-
Trastuzumab treatment in patients with breast cancer and metastatic CNS disease
-
1:STN:280:DC%2BC3c3ptFOmtA%3D%3D 19717536
-
Pienkowski T, Zielinski CC. Trastuzumab treatment in patients with breast cancer and metastatic CNS disease. Ann Oncol. 2010;21(5):917-24.
-
(2010)
Ann Oncol
, vol.21
, Issue.5
, pp. 917-924
-
-
Pienkowski, T.1
Zielinski, C.C.2
-
31
-
-
33847063053
-
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
-
1:CAS:528:DC%2BD2sXkt1enur0%3D 17438091
-
Carey LA, Claire DE, Sawyer L, Gatti L, Moore DT, Collichio F, et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes. Clin Cancer Res. 2007;13:2329-34.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2329-2334
-
-
Carey, L.A.1
Claire, D.E.2
Sawyer, L.3
Gatti, L.4
Moore, D.T.5
Collichio, F.6
Ollila, D.W.7
Sartor, C.I.8
Graham, M.L.9
Perou, C.M.10
-
32
-
-
77949908546
-
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
-
1:CAS:528:DC%2BC3cXktF2ltLk%3D 2834466 20100965
-
Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, et al. Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer. J Clin Oncol. 2010;28(7):1145-53.
-
(2010)
J Clin Oncol
, vol.28
, Issue.7
, pp. 1145-1153
-
-
Silver, D.P.1
Richardson, A.L.2
Eklund, A.C.3
Wang, Z.C.4
Szallasi, Z.5
Li, Q.6
Juul, N.7
Leong, C.-O.8
Calogrias, D.9
Buraimoh, A.10
Fatima, A.11
Gelman, R.S.12
Ryan, P.D.13
Tung, N.M.14
De Nicolo, A.15
Ganesan, S.16
Miron, A.17
Colin, C.18
Sgroi, D.C.19
Ellisen, L.W.20
Winer, E.P.21
Garber, J.E.22
more..
-
33
-
-
55949092708
-
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
-
1:CAS:528:DC%2BD1cXhtlKlsr7F 2579381 18971340
-
Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A. 2008;105(44):17079-84.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.44
, pp. 17079-17084
-
-
Rottenberg, S.1
Jaspers, J.E.2
Kersbergen, A.3
Van Der Burg, E.4
Nygren, A.O.5
Zander, S.A.6
Derksen, P.W.7
De Bruin, M.8
Zevenhoven, J.9
Lau, A.10
Boulter, R.11
Cranston, A.12
O'Connor, M.J.13
Martin, N.M.14
Borst, P.15
Jonkers, J.16
-
34
-
-
84876671239
-
Factors associated with the frequency of initial total mastectomy: Results of a multi-institutional study
-
3678356 23490543
-
Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, et al. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013;216(5):966-75.
-
(2013)
J Am Coll Surg
, vol.216
, Issue.5
, pp. 966-975
-
-
Feigelson, H.S.1
James, T.A.2
Single, R.M.3
Onitilo, A.A.4
Aiello Bowles, E.J.5
Barney, T.6
Bakerman, J.E.7
McCahill, L.E.8
-
35
-
-
84862172043
-
Temporal trends in the surgical outcomes of patients with breast cancer
-
3536705 22697184
-
Hanagiri T, Nagata Y, Monji S, Shinohara S, Takenaka M, Shigematsu Y, et al. Temporal trends in the surgical outcomes of patients with breast cancer. World J Surg Oncol. 2012;10:108.
-
(2012)
World J Surg Oncol
, vol.10
, pp. 108
-
-
Hanagiri, T.1
Nagata, Y.2
Monji, S.3
Shinohara, S.4
Takenaka, M.5
Shigematsu, Y.6
Shimokawa, H.7
Nakagawa, M.8
Uramoto, H.9
So, T.10
Tanaka, F.11
-
36
-
-
73349099064
-
Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients
-
19653046
-
McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682-90.
-
(2009)
Ann Surg Oncol
, vol.16
, Issue.10
, pp. 2682-2690
-
-
McGuire, K.P.1
Santillan, A.A.2
Kaur, P.3
Meade, T.4
Parbhoo, J.5
Mathias, M.6
Shamehdi, C.7
Davis, M.8
Ramos, D.9
Cox, C.E.10
-
37
-
-
79955876613
-
Mastectomy and contralateral prophylactic mastectomy rates: An institutional review
-
21125335
-
Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review. Ann Surg Oncol. 2011;18(5):1356-63.
-
(2011)
Ann Surg Oncol
, vol.18
, Issue.5
, pp. 1356-1363
-
-
Damle, S.1
Teal, C.B.2
Lenert, J.J.3
Marshall, E.C.4
Pan, Q.5
McSwain, A.P.6
-
38
-
-
84865121178
-
Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database
-
22483323
-
Garcia-Etienne CA, Tomatis M, Heil J, Friedrichs K, Kreienberg R, Denk A, et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer. 2012;48(13):1947-56.
-
(2012)
Eur J Cancer
, vol.48
, Issue.13
, pp. 1947-1956
-
-
Garcia-Etienne, C.A.1
Tomatis, M.2
Heil, J.3
Friedrichs, K.4
Kreienberg, R.5
Denk, A.6
Kiechle, M.7
Lorenz-Salehi, F.8
Kimmig, R.9
Emons, G.10
Danaei, M.11
Heyl, V.12
Heindrichs, U.13
Rageth, C.J.14
Janni, W.15
Marotti, L.16
Del Turco, M.R.17
Ponti, A.18
-
39
-
-
84863717818
-
Increasing mastectomy rates among all age groups for early stage breast cancer: A 10-year study of surgical choice
-
22607016
-
Dragun AE, Huang B, Tucker TC, Spanos WJ. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. 2012;18(4):318-25.
-
(2012)
Breast J
, vol.18
, Issue.4
, pp. 318-325
-
-
Dragun, A.E.1
Huang, B.2
Tucker, T.C.3
Spanos, W.J.4
-
40
-
-
84880070478
-
Increasing national mastectomy rates for the treatment of early stage breast cancer
-
23135312
-
Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013;20(5):1436-43.
-
(2013)
Ann Surg Oncol
, vol.20
, Issue.5
, pp. 1436-1443
-
-
Mahmood, U.1
Hanlon, A.L.2
Koshy, M.3
Buras, R.4
Chumsri, S.5
Tkaczuk, K.H.6
Cheston, S.B.7
Regine, W.F.8
Feigenberg, S.J.9
-
41
-
-
84878885356
-
Fluctuating mastectomy rates across time and geography
-
23640480
-
Garcia-Etienne CA, Tomatis M, Heil J, Danaei M, Rageth CJ, Marotti L, et al. Fluctuating mastectomy rates across time and geography. Ann Surg Oncol. 2013;20(7):2114-6.
-
(2013)
Ann Surg Oncol
, vol.20
, Issue.7
, pp. 2114-2116
-
-
Garcia-Etienne, C.A.1
Tomatis, M.2
Heil, J.3
Danaei, M.4
Rageth, C.J.5
Marotti, L.6
Rosselli Del Turco, M.7
Ponti, A.8
-
42
-
-
79953051295
-
Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study
-
1:STN:280:DC%2BC3c%2FotVSgsw%3D%3D 2810246 20126325
-
Clegg-Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in ghana? A pilot study. Ghana Med J. 2009;43(3):127-31.
-
(2009)
Ghana Med J
, vol.43
, Issue.3
, pp. 127-131
-
-
Clegg-Lamptey, J.1
Dakubo, J.2
Attobra, Y.N.3
|